PriceTargets.com logo

Akumin - AKU Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.00 As of 10/25/2023 05:00 PM ET
+0 (0.00%)
Get New Akumin Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AKU and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AKU

Analyst Price Target is $0.00
This price target is based on 1 analysts offering 12 month price targets for Akumin in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.

This chart shows the closing price for AKU for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 1 polled investment analysts is to hold stock in Akumin. This rating has held steady since May 2024, when it changed from a Reduce consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
4/15/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
7/14/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
10/12/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
1/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
4/9/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
7/8/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/6/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/6/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/23/2023Clarus SecuritiesReiterated RatingSpeculative Buy ➝ Hold
8/11/2023Clarus SecuritiesReiterated RatingBuy ➝ Speculative Buy
5/16/2023National BanksharesLower TargetUnderperform$0.50 ➝ $0.25
8/11/2022National BanksharesLower TargetUnderperform$0.75 ➝ $0.50
2/2/2022National Bank FinancialDowngradeSector Perform ➝ Underperform$2.00 ➝ $0.75
2/2/2022National BanksharesDowngradeSector Perform ➝ Underperform$2.00 ➝ $0.75
11/9/2021National Bank FinancialLower TargetSector Perform$3.50 ➝ $2.00
11/9/2021National BanksharesLower TargetSector Perform$3.50 ➝ $2.00
9/2/2021Clarus SecuritiesBoost TargetBuy$6.00 ➝ $8.00
6/28/2021National Bank FinancialBoost TargetSector Perform$3.25 ➝ $3.50
6/28/2021National BanksharesBoost TargetSector Perform$3.25 ➝ $3.50
2/9/2021Clarus SecuritiesReiterated RatingBuy
(Data available from 10/7/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/11/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/10/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/10/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/9/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/9/2024
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/8/2024
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/7/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/7/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Akumin logo
Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to hospitals and health systems across 48 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $0.18
Low: $0.13
High: $0.36

52 Week Range

Now: N/A

Volume

8,543,300 shs

Average Volume

1,379,745 shs

Market Capitalization

$26.32 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Akumin?

The following equities research analysts have issued research reports on Akumin in the last twelve months: Clarus Securities.
View the latest analyst ratings for AKU.

What is the current price target for Akumin?

0 Wall Street analysts have set twelve-month price targets for Akumin in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Akumin in the next year.
View the latest price targets for AKU.

What is the current consensus analyst rating for Akumin?

Akumin currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in AKU, but not buy more shares or sell existing shares.
View the latest ratings for AKU.

What other companies compete with Akumin?

Other companies that are similar to Akumin include Enzo Biochem, Exagen, Burning Rock Biotech, Renalytix and Psychemedics. Learn More about companies similar to Akumin.

How do I contact Akumin's investor relations team?

The company's listed phone number is (844) 730-0050. The official website for Akumin is www.akumin.com. Learn More about contacing Akumin investor relations.